相似文献
1
FDA regulation of genetic testing: institutional reluctance and public guardianship.
Food Drug Law J. 1998;53(3):555-91.
2
A public health perspective on the control of predictive screening for breast cancer.
Health Matrix Clevel. 1997 Winter;7(1):31-48.
3
FDA to regulate direct-to-consumer genetic tests.
J Natl Cancer Inst. 2010 Nov 3;102(21):1610-2, 1617. doi: 10.1093/jnci/djq446. Epub 2010 Oct 21.
4
In search of a coherent framework: options for FDA oversight of genetic tests.
Food Drug Law J. 2007;62(4):617-52.
5
[Federal judge and government of the United States against gene patenting].
Med Sci (Paris). 2011 Jun-Jul;27(6-7):662-6. doi: 10.1051/medsci/2011276020. Epub 2011 Jul 1.
6
FDA approves genetic test for women with breast cancer.
BMJ. 1998 Jan 17;316(7126):168.
7
Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
Tulane Law Rev. 1997 Mar;71(4):1211-312.
8
Jewish theological and moral reflections on genetic screening: the case of BRCA1.
Health Matrix Clevel. 1997 Winter;7(1):65-96.
9
The FDA is coming! The FDA is coming!
Mol Diagn. 2001 Sep;6(3):153-4. doi: 10.1054/modi.2001.0060153.
10
Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Oklahoma Law Rev. 2004 Summer;57(2):251-302.
引用本文的文献
1
Framing utility: Regulatory reform and genetic tests in the USA, 1989-2000.
Soc Sci Med. 2022 Jul;304:112924. doi: 10.1016/j.socscimed.2020.112924. Epub 2020 Mar 19.
2
FDA's Proposed Guidance for Laboratory Developed Tests: How Should Regulators Balance the Risks and Promise of Innovation in Clinical Genetics?
FDLIs Food Drug Policy Forum. 2015 Mar;5(2). Epub 2015 Feb 25.
Zotero 插件